Anixa Biosciences, Inc.

Nasdaq: ANIX
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisors
  • Therapeutics
    • CAR-T
      • Introduction
      • Markets
      • Science
      • Collaborators
    • Breast Cancer Vaccine
      • Introduction
      • Markets
      • Science
      • Collaborators
  • Diagnostics
    • Cchek™
    • Markets
    • Science
    • Collaborators
  • Pipeline
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
      • Events
      • Corporate Presentation
    • Stock Information
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • SEC Filings
    • Financial Reports
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Governance Documents
      • Committee Charters
  • News
    • Press Releases
    • Anixa In The News
    • Presentations
    • Publications
  • Contact Us

News Releases

Investors

Investors

  • Overview
  • News Releases
  • Events & Presentations
    • Events
    • Corporate Presentation
  • Stock Info
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
  • Financial Reports
    • Annual Reports
    • Quarterly Reports
  • Governance
    • Governance Documents
    • Committee Charters
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
    • RSS News Feed
  • All News
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015

Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board

October 10, 2019

Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study

September 23, 2019

Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek™ Prostate Cancer Study

September 19, 2019

Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

September 16, 2019

Anixa Biosciences to Present at Two Upcoming Investor Conferences

August 26, 2019

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study

July 29, 2019

Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology

July 24, 2019

Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek™ Prostate Cancer Study

July 22, 2019

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

July 17, 2019

Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells

July 16, 2019

RSS
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...14
  • Next »

Sign up for email Updates

Be The First to Receive Breaking News

Sign Up Now
Logo Itus

Latest News & Events

Dec 2, 2019

Anixa Biosciences Announces Presentation at the 2019 San Antonio Breast Cancer Symposium

Read More...
Nov 26, 2019

Anixa Biosciences Announces Genesis Research to Join Cchek™ Prostate Cancer Study

Read More...
Nov 22, 2019

Anixa Biosciences Announces Collaboration with Urology Centers of Alabama on Cchek™ Prostate Cancer Study

Read More...

Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.

Copyrights © 2019 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap